Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
20-Aug-2016ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancerAli, S; Patel, H; Periyasamy, M; Bondke, A; Slafer, BW, et al
17-Oct-2016Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancerHarrod, A; Fulton, J; Nguyen, VTM; Periyasamy, M; Ramos Garcia, L, et al
1-Aug-2016Cytidine deamination activity of APOBEC3B regulates estrogen receptor function in breast cancerPeriyasamy, M; Nguyen, VTM; Patel, H; Lai, C-F; Nevedomskaya, E, et al
30-Nov-2017Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.Martin, L-A; Ribas, R; Simigdala, N; Schuster, E; Pancholi, S, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
24-Sep-2015APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancerAli, S; Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM, et al
14-Jun-2016Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancerPatel, H; Abduljabbar, R; Chun-Fui, L; Periyasamy, M; Harrod, A, et al